ANDERSON KERRII B
SEC CIK 1227159 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| LH | Labcorp | Dir | 6,563 | — | $5.15M | 17 | 2021-12-14 | 2026-08-17 |
| SHW | Sherwin-Williams | Dir | 1,076 | — | — | 26 | 2021-07-02 | 2026-07-06 |
| ANF | ABERCROMBIE & FITCH CO /DE/ | Dir | 38.7K | $35.2K | $2.09M | 10 | 2021-09-02 | 2026-06-03 |
| WOR | WORTHINGTON ENTERPRISES, INC. | Dir | 74.1K | — | $360.0K | 8 | 2021-09-03 | 2025-09-25 |
Most active insiders at LH, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Schechter Adam H | Pres, CEO, Dir | — | $8.44M |
| 2 | Parham Richelle P | Dir | — | $1.78M |
| 3 | Wilkinson Peter J | SVP, CAO | — | $1.06M |
| 4 | ANDERSON KERRII B | Dir | — | $954.1K |
| 5 | Caveney Brian J | EVP, CMO, CSO, Pres of ED | — | $429.5K |
| 6 | Meltzer Jonathan C | EVP, Ops | — | $298.8K |
| 7 | Summy Amy B. | EVP, CMO | — | $283.4K |
| 8 | Kyle Kathryn W | EVP, CLO | — | $227.4K |
| 9 | van der Vaart Sandra D | EVP, Corp. Affairs | — | $156.0K |
| 10 | Vaughn Bryan T | EVP, Pres, Diagnostics | — | $67.0K |
Transactions 61
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-08-18 08:10 | 2026-08-17 | LH | Labcorp | ANDERSON KERRII B | Dir | S - Sale | $318.02 | -3,000 | 6,563 | -31% | -$954.1K |
| I | 2026-07-08 13:21 | 2026-07-06 | SHW | Sherwin-Williams | ANDERSON KERRII B | Dir | A - Grant | $350.40 | +28.54 | 1,076 | +3% | +$10.0K |
| D | 2026-06-05 17:09 | 2026-06-03 | ANF | ABERCROMBIE & FITCH CO /DE/ | ANDERSON KERRII B | Dir | M - OptEx | $0.00 | +1,567 | 38.7K | +4% | $0 |
| I | 2026-04-08 17:07 | 2026-04-06 | SHW | Sherwin-Williams | ANDERSON KERRII B | Dir | A - Grant | $315.50 | +31.70 | 1,045 | +3% | +$10.0K |
| 2026-02-17 | 2026-02-17 | SHW | Sherwin-Williams | ANDERSON KERRII B | Dir | A - Grant | $0.00 | +558 | 5,819 | +11% | $0 | |
| D | 2026-02-13 | 2026-02-11 | LH | Labcorp | ANDERSON KERRII B | Dir | M - OptEx | — | +897 | 9,563 | +10% | — |
| I | 2026-01-13 | 2026-01-09 | SHW | Sherwin-Williams | ANDERSON KERRII B | Dir | A - Grant | $345.60 | +28.94 | 1,011 | +3% | +$10.0K |
| I | 2025-10-07 | 2025-10-03 | SHW | Sherwin-Williams | ANDERSON KERRII B | Dir | A - Grant | $343.81 | +29.09 | 979.69 | +3% | +$10.0K |
| 2025-09-26 | 2025-09-25 | WOR | WORTHINGTON ENTERPRISES, INC. | ANDERSON KERRII B | Dir | A - Grant | $0.00 | +2,815 | 74.1K | +4% | $0 | |
| 2025-09-03 | 2025-08-29 | ANF | ABERCROMBIE & FITCH CO /DE/ | ANDERSON KERRII B | Dir | S - Sale | $95.12 | -4,292 | 37.2K | -10% | -$408.3K | |
| 2025-07-28 | 2025-07-24 | LH | Labcorp | ANDERSON KERRII B | Dir | S - Sale | $280.00 | -3,500 | 8,666 | -29% | -$980.0K | |
| 2025-07-28 | 2025-07-24 | LH | Labcorp | ANDERSON KERRII B | Dir | S - Sale | $280.00 | -3,500 | 8,666 | -29% | -$980.0K | |
| I | 2025-07-09 | 2025-07-07 | SHW | Sherwin-Williams | ANDERSON KERRII B | Dir | A - Grant | $346.53 | +28.86 | 948.59 | +3% | +$10.0K |
| 2025-07-02 | 2025-07-01 | LH | Labcorp | ANDERSON KERRII B | Dir | S - Sale | $265.00 | -500 | 12.2K | -4% | -$132.5K | |
| D | 2025-06-13 | 2025-06-11 | ANF | ABERCROMBIE & FITCH CO /DE/ | ANDERSON KERRII B | Dir | M - OptEx | $0.00 | +780 | 41.5K | +2% | $0 |
| 2025-06-12 | 2025-06-11 | LH | Labcorp | ANDERSON KERRII B | Dir | S - Sale | $260.00 | -500 | 12.7K | -4% | -$130.0K | |
| I | 2025-04-07 | 2025-04-04 | SHW | Sherwin-Williams | ANDERSON KERRII B | Dir | A - Grant | $338.25 | +29.56 | 917.73 | +3% | +$9,999 |
| 2025-03-07 | 2025-03-05 | LH | Labcorp | ANDERSON KERRII B | Dir | S - Sale | $255.63 | -500 | 13.2K | -4% | -$127.8K | |
| 2025-02-20 | 2025-02-18 | SHW | Sherwin-Williams | ANDERSON KERRII B | Dir | A - Grant | $0.00 | +517 | 5,261 | +11% | $0 | |
| D | 2025-02-10 | 2025-02-06 | LH | Labcorp | ANDERSON KERRII B | Dir | M - OptEx | — | +944 | 13.7K | +7% | — |
| 2025-01-08 | 2025-01-07 | LH | Labcorp | ANDERSON KERRII B | Dir | S - Sale | $235.00 | -1,000 | 12.7K | -7% | -$235.0K | |
| I | 2025-01-07 | 2025-01-03 | SHW | Sherwin-Williams | ANDERSON KERRII B | Dir | A - Grant | $335.00 | +29.85 | 886.12 | +3% | +$10,000 |
| 2024-12-04 | 2024-12-03 | ANF | ABERCROMBIE & FITCH CO /DE/ | ANDERSON KERRII B | Dir | G - Gift | $0.00 | -2,000 | 40.7K | -5% | $0 | |
| 2024-10-25 | 2024-10-24 | LH | Labcorp | ANDERSON KERRII B | Dir | S - Sale | $230.00 | -1,000 | 13.7K | -7% | -$230.0K | |
| I | 2024-10-08 | 2024-10-04 | SHW | Sherwin-Williams | ANDERSON KERRII B | Dir | A - Grant | $372.47 | +26.85 | 854.69 | +3% | +$10.0K |
| 2024-09-27 | 2024-09-26 | WOR | WORTHINGTON ENTERPRISES, INC. | ANDERSON KERRII B | Dir | A - Grant | $0.00 | +3,300 | 71.3K | +5% | $0 | |
| M | 2024-08-09 | 2024-08-07+ | LH | Labcorp | ANDERSON KERRII B | Dir | S - Sale | $225.00 | -1,000 | 15.3K | -6% | -$225.0K |
| I | 2024-07-09 | 2024-07-05 | SHW | Sherwin-Williams | ANDERSON KERRII B | Dir | A - Grant | $295.50 | +33.84 | 826.22 | +4% | +$10,000 |
| D | 2024-06-12 | 2024-06-10 | ANF | ABERCROMBIE & FITCH CO /DE/ | ANDERSON KERRII B | Dir | M - OptEx | $0.00 | +4,292 | 42.7K | +11% | $0 |
| M | 2024-06-04 | 2024-05-31 | ANF | ABERCROMBIE & FITCH CO /DE/ | ANDERSON KERRII B | Dir | S - Sale | $172.72 | -7,500 | 43.9K | -15% | -$1.30M |
| M | 2024-05-02 | 2024-04-30+ | LH | Labcorp | ANDERSON KERRII B | Dir | S - Sale | $202.12 | -500 | 15.7K | -3% | -$101.1K |
| I | 2024-04-09 | 2024-04-05 | SHW | Sherwin-Williams | ANDERSON KERRII B | Dir | A - Grant | $331.56 | +30.16 | 790.45 | +4% | +$10,000 |
| M | 2024-03-11 | 2024-03-08 | ANF | ABERCROMBIE & FITCH CO /DE/ | ANDERSON KERRII B | Dir | S - Sale | $127.33 | -3,000 | 45.9K | -6% | -$382.0K |
| 2024-02-15 | 2024-02-13 | SHW | Sherwin-Williams | ANDERSON KERRII B | Dir | A - Grant | $0.00 | +594 | 4,744 | +14% | $0 | |
| D | 2024-02-08 | 2024-02-07 | LH | Labcorp | ANDERSON KERRII B | Dir | M - OptEx | — | +947 | 16.2K | +6% | — |
| I | 2024-01-09 | 2024-01-05 | SHW | Sherwin-Williams | ANDERSON KERRII B | Dir | A - Grant | $296.96 | +33.67 | 758.72 | +5% | +$9,999 |
| I | 2023-10-10 | 2023-10-06 | SHW | Sherwin-Williams | ANDERSON KERRII B | Dir | A - Grant | $253.15 | +38.27 | 723.54 | +6% | +$9,688 |
| 2023-10-02 | 2023-09-29 | WOR | WORTHINGTON ENTERPRISES, INC. | ANDERSON KERRII B | Dir | A - Grant | $0.00 | +2,300 | 66.7K | +4% | $0 | |
| 2023-08-10 | 2023-08-08 | LH | Labcorp | ANDERSON KERRII B | Dir | S - Sale | $211.57 | -5,000 | 15.3K | -25% | -$1.06M | |
| 2023-08-08 | 2023-08-07 | WOR | WORTHINGTON ENTERPRISES, INC. | ANDERSON KERRII B | Dir | S - Sale | $72.00 | -5,000 | 64.4K | -7% | -$360.0K | |
| I | 2023-07-10 | 2023-07-07 | SHW | Sherwin-Williams | ANDERSON KERRII B | Dir | A - Grant | $257.00 | +37.70 | 683.75 | +6% | +$9,689 |
| D | 2023-06-12 | 2023-06-08 | ANF | ABERCROMBIE & FITCH CO /DE/ | ANDERSON KERRII B | Dir | M - OptEx | $0.00 | +7,565 | 48.9K | +18% | $0 |
| I | 2023-04-12 | 2023-04-10 | SHW | Sherwin-Williams | ANDERSON KERRII B | Dir | A - Grant | $223.68 | +43.31 | 644.43 | +7% | +$9,688 |
| 2023-02-16 | 2023-02-14 | SHW | Sherwin-Williams | ANDERSON KERRII B | Dir | A - Grant | $0.00 | +711 | 4,150 | +21% | $0 | |
| D | 2023-02-14 | 2023-02-11 | LH | Labcorp | ANDERSON KERRII B | Dir | M - OptEx | — | +742 | 20.3K | +4% | — |
| I | 2023-01-10 | 2023-01-06 | SHW | Sherwin-Williams | ANDERSON KERRII B | Dir | A - Grant | $232.66 | +41.64 | 599.45 | +7% | +$9,688 |
| I | 2022-10-11 | 2022-10-07 | SHW | Sherwin-Williams | ANDERSON KERRII B | Dir | A - Grant | $209.43 | +46.26 | 556.47 | +9% | +$9,688 |
| 2022-09-30 | 2022-09-28 | WOR | WORTHINGTON ENTERPRISES, INC. | ANDERSON KERRII B | Dir | A - Grant | $0.00 | +2,700 | 69.4K | +4% | $0 | |
| I | 2022-07-12 | 2022-07-08 | SHW | Sherwin-Williams | ANDERSON KERRII B | Dir | A - Grant | $237.91 | +40.72 | 508.95 | +9% | +$9,688 |
| D | 2022-06-10 | 2022-06-08 | ANF | ABERCROMBIE & FITCH CO /DE/ | ANDERSON KERRII B | Dir | M - OptEx | $0.00 | +2,711 | 41.3K | +7% | $0 |
| I | 2022-04-12 | 2022-04-08 | SHW | Sherwin-Williams | ANDERSON KERRII B | Dir | A - Grant | $264.59 | +36.61 | 467.73 | +8% | +$9,687 |
| 2022-02-17 | 2022-02-15 | SHW | Sherwin-Williams | ANDERSON KERRII B | Dir | A - Grant | $0.00 | +529 | 3,439 | +18% | $0 | |
| DM | 2022-02-04 | 2021-12-14 | LH | Labcorp | ANDERSON KERRII B | Dir | G - Gift | $0.00 | -1,550 | 20.0K | -7% | $0 |
| D | 2022-02-04 | 2022-02-02 | LH | Labcorp | ANDERSON KERRII B | Dir | M - OptEx | — | +771 | 19.5K | +4% | — |
| I | 2022-01-11 | 2022-01-07 | SHW | Sherwin-Williams | ANDERSON KERRII B | Dir | A - Grant | $327.94 | +29.54 | 430.04 | +7% | +$9,687 |
| 2021-12-22 | 2021-12-20 | WOR | WORTHINGTON ENTERPRISES, INC. | ANDERSON KERRII B | Dir | G - Gift | $0.00 | -3,000 | 66.7K | -4% | $0 | |
| MI | 2021-10-14 | 2021-09-03 | WOR | WORTHINGTON ENTERPRISES, INC. | ANDERSON KERRII B | Dir | G - Gift | $0.00 | 0 | 0 | New | $0 |
| I | 2021-10-13 | 2021-10-08 | SHW | Sherwin-Williams | ANDERSON KERRII B | Dir | A - Grant | $291.45 | +31.74 | 399.86 | +9% | +$9,251 |
| 2021-09-30 | 2021-09-29 | WOR | WORTHINGTON ENTERPRISES, INC. | ANDERSON KERRII B | Dir | A - Grant | $0.00 | +2,400 | 67.5K | +4% | $0 | |
| 2021-09-02 | 2021-09-02 | ANF | ABERCROMBIE & FITCH CO /DE/ | ANDERSON KERRII B | Dir | P - Purchase | $35.17 | +1,000 | 38.6K | +3% | +$35.2K | |
| I | 2021-07-07 | 2021-07-02 | SHW | Sherwin-Williams | ANDERSON KERRII B | Dir | A - Grant | $274.96 | +33.64 | 367.44 | +10% | +$9,250 |
Purchase Sale Sale after option exercise All abbreviations